Page last updated: 2024-10-20

diphosphoric acid and Neurofibromatosis 1

diphosphoric acid has been researched along with Neurofibromatosis 1 in 1 studies

diphosphoric acid : An acyclic phosphorus acid anhydride obtained by condensation of two molecules of phosphoric acid.

Neurofibromatosis 1: An autosomal dominant inherited disorder (with a high frequency of spontaneous mutations) that features developmental changes in the nervous system, muscles, bones, and skin, most notably in tissue derived from the embryonic NEURAL CREST. Multiple hyperpigmented skin lesions and subcutaneous tumors are the hallmark of this disease. Peripheral and central nervous system neoplasms occur frequently, especially OPTIC NERVE GLIOMA and NEUROFIBROSARCOMA. NF1 is caused by mutations which inactivate the NF1 gene (GENES, NEUROFIBROMATOSIS 1) on chromosome 17q. The incidence of learning disabilities is also elevated in this condition. (From Adams et al., Principles of Neurology, 6th ed, pp1014-18) There is overlap of clinical features with NOONAN SYNDROME in a syndrome called neurofibromatosis-Noonan syndrome. Both the PTPN11 and NF1 gene products are involved in the SIGNAL TRANSDUCTION pathway of Ras (RAS PROTEINS).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
de la Croix Ndong, J1
Makowski, AJ1
Uppuganti, S1
Vignaux, G1
Ono, K1
Perrien, DS1
Joubert, S1
Baglio, SR1
Granchi, D1
Stevenson, DA1
Rios, JJ1
Nyman, JS1
Elefteriou, F1

Other Studies

1 other study available for diphosphoric acid and Neurofibromatosis 1

ArticleYear
Asfotase-α improves bone growth, mineralization and strength in mouse models of neurofibromatosis type-1.
    Nature medicine, 2014, Volume: 20, Issue:8

    Topics: Adolescent; Alkaline Phosphatase; Animals; Bone Development; Bone Diseases, Developmental; Bone Morp

2014